SOMERVILLE, MA, USA, Sep 14, 2022 – Formlabs, the leading 3D printing company, announced the appointment of Guillaume Bailliard as the president of the company’s newly formed healthcare division. Formlabs has pioneered 3D printing accessibility in dental and medical industries, having sold more than 25,000 healthcare 3D printers, making it the most installed 3D printing company in the market. With this new division, Formlabs is now further focusing on the fast growing 3D printing healthcare market enabling the company to better serve provider, medical device firms, and clinician and patient needs.
The healthcare sector is rapidly embracing the value and benefits of 3D printing in medical and dental applications, from personalized care and medical devices to real-time modeling and patient education. Rising public support and funding for 3D printing in healthcare, and adoption of digital workflows and manufacturing has set the stage for 3D printing in these markets to grow in the next few years. The affordability and accessibility of Formlabs 3D printing solutions and materials have enabled medical and dental applications to flourish as a flexible solution that also meets the requirements for medical devices, dentures, implants, prosthetics, and more.
With key partnerships, including becoming the first 3D printing company listed in a major group purchasing organization (GPO) catalog, Formlabs is uniquely positioned as a leader in the market. With the appointment of Bailliard, Formlabs is doubling down on delivering 3D printing solutions to support advancement in medical and dental applications. Bailliard brings more than 25 years of experience in the healthcare market, previously serving in a variety of leadership roles in early-stage healthcare companies and within GE Healthcare for nearly a decade. In his new role, Bailliard will further build out the business unit to address both markets, creating a global growth strategy spanning product development and go-to-market planning.
“Formlabs is a driving force in advancing 3D printing adoption in the healthcare sector, pioneering materials and solutions that enable the industry to innovate and improve patient care. Recognizing that medical and dental applications present unique opportunities for providers to adopt and implement this technology, Formlabs has appointed Guillaume to spearhead our strategic growth in this category,” said Max Lobovsky, Formlabs CEO. “With his background working with healthcare leaders as well as early-stage startups, Guillaume can address the unique challenges of advancing Formlabs’ 3D printing in these markets.”
“3D printing in healthcare is an exciting opportunity that can streamline workflows, enable precision healthcare, and improve patient outcomes. Formlabs has been at the forefront of this innovation, with solutions that have enabled the industry to capture the benefits of 3D printing technology,” said Formlabs President, Healthcare Guillaume Bailliard. “I’m thrilled to lead Formlabs’ growth in the medical and dental industries.”
For more information about Formlabs, visit formlabs.com.
About Formlabs Healthcare
Formlabs is expanding access to digital fabrication, so anyone can make anything. By combining clinically-validated 3D printing technology, in-house QA/RA expertise, accessible pricing, and a wide range of materials, the company enables healthcare professionals and medical device engineers to enhance surgery, radiology, orthotics and prosthetics, and device development. Formlabs has FDA-registered, ISO 13485 certified manufacturing facilities and a wide range of biocompatible, sterilizable materials made for both SLA and SLS print engines. Its solutions have been used in thousands of publications and are trusted by the world’s leading health systems and medical device manufacturers.